Newsroom

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

by Neoteryx, on April 22,2021

At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …

Read Story
Topics:

by Neoteryx, on March 25,2021

According to a March 12, 2021 article by Adam Bonislawski in Genomeweb, researchers at Stanford University are profiling responses to the COVID-19 vaccinations. The Stanford study investigates the effects of …

Read Story
Topics:

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story
Topics:

by Neoteryx, on February 5,2021

LONDON — February 2021 — A home specimen collection service launched in late 2020 by Guy's and St Thomas, an NHS Foundation Trust hospital in London, is designed to keep …

Read Story
Topics:

by Neoteryx, on January 4,2021

Mitra Microsamples Help NIH Measure SARS-CoV-2 Raised Antibodies With 99-100% Accuracy LOS ANGELES / BETHESDA, MD — JANUARY 4, 2021 — After launching a “serosurvey” to track undetected cases of …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news